![Daniel Yerace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 656 644 $ am 31.05.2026
Daniel Yerace is the founder of Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. Mr. Yerace is currently Director & Vice President-Operations at Coeptis Therapeutics Holdings, Inc. since 2022.
Formerly, Mr. Yerace was Senior Director-Global Supply Chain at Kadmon Pharmaceuticals LLC.
Mr. Yerace completed undergraduate and MBA degrees at Waynesburg University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.14% | 11.02.2026 | 70’531 ( 0.14% ) | 656 644 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NAERODYNAMICS INC | Gründer | - |
Coeptis Pharmaceuticals, Inc.
 Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Gründer | - |
| Unternehmen | Position | Ende |
|---|---|---|
| COEPTIS THERAPEUTICS | Geschäftsführer | - |
Kadmon Pharmaceuticals LLC
 Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Coeptis Therapeutics, Inc.
 Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Waynesburg College
 Waynesburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Coeptis Therapeutics Holdings, Inc.
 Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
